Tong Calvin K W, Khush Kiran K
Cardiovascular Medicine, Stanford University, 300 Pasteur Drive, Falk CVRC 263, Stanford, CA 94305 USA.
Curr Treat Options Cardiovasc Med. 2021;23(5):28. doi: 10.1007/s11936-021-00906-5. Epub 2021 Mar 23.
With increasing survival of patients with stage D heart failure, the demand for heart transplantation has increased. The supply of donor hearts remains relatively limited. Strategies have been investigated and new technologies have been developed to expand the current donor pool. These new approaches will be discussed herein.
Donor hearts are often considered "marginal" due to risk factors such as older age, size mismatch with the intended recipient, prolonged ischemic time, presence of left ventricular hypertrophy, and hepatitis B/C infection. We reviewed recent data regarding the use of donor hearts with these risk factors and suggest ways to safely liberalize current donor heart acceptance criteria. New technologies such as temperature-controlled transport systems and ex vivo cardiac perfusion methods have also demonstrated promising short-term and intermediate outcomes as compared with routine cold storage, by promoting heart preservation and enabling heart procurement from remote sites with shorter cold ischemic time. Recent use of hearts from donation after circulatory death donors has demonstrated comparable outcomes to conventional donation after brain death, which can further expand the current donor pool.
Careful selection of "marginal" donor hearts, use of ex vivo cardiac perfusion, and acceptance of hearts after circulatory death may expand our current cardiac donor pool with comparable outcomes to conventional donor selection and preparation methods.
随着D期心力衰竭患者生存率的提高,心脏移植的需求增加。供体心脏的供应仍然相对有限。已对多种策略进行了研究,并开发了新技术以扩大当前的供体库。本文将讨论这些新方法。
由于年龄较大、与预期受体的大小不匹配、缺血时间延长、左心室肥厚以及乙肝/丙肝感染等风险因素,供体心脏常被视为“边缘性”的。我们回顾了有关使用具有这些风险因素的供体心脏的最新数据,并提出了安全放宽当前供体心脏接受标准的方法。与常规冷藏相比,诸如温控运输系统和体外心脏灌注方法等新技术通过促进心脏保存并允许从冷缺血时间较短的偏远地点获取心脏,也已显示出有希望的短期和中期结果。最近使用循环死亡后供体的心脏已显示出与传统脑死亡后供体相当的结果,这可以进一步扩大当前的供体库。
谨慎选择“边缘性”供体心脏、使用体外心脏灌注以及接受循环死亡后的心脏,可能会扩大我们当前的心脏供体库,其结果与传统的供体选择和处理方法相当。